Trials / Conditions / PD-L1 Negative
PD-L1 Negative
4 registered clinical trials studyying PD-L1 Negative — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Neoadjuvant Immunochemotherapy in PD-L1-negative LACC NCT06288360 | Tongji Hospital | Phase 2 |
| Active Not Recruiting | Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreat NCT05382299 | Gilead Sciences | Phase 3 |
| Recruiting | Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC NCT04468061 | Dana-Farber Cancer Institute | Phase 2 |
| Active Not Recruiting | Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who NCT03546426 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Phase 1 |